Indications for use of bicarbonate in patients with metabolic acidosis.
Arieff
A I
AI
Department of Medicine, Veterans Affairs Medical Center, San Francisco, California 94121.
D000138:Acidosis / Q000628:therapy*; D000818:Animals; D001639:Bicarbonates / Q000009:adverse effects / Q000627:therapeutic use*; D002021:Buffers; D002245:Carbon Dioxide / Q000097:blood; D002254:Carbonates / Q000627:therapeutic use; D003999:Dichloroacetic Acid / Q000627:therapeutic use; D004338:Drug Combinations; D005440:Fluid Therapy; D006801:Humans; D000860:Hypoxia / Q000628:therapy; D010100:Oxygen / Q000097:blood; D012964:Sodium / Q000009:adverse effects / Q000627:therapeutic use*; D017693:Sodium Bicarbonate; D014325:Tromethamine / Q000627:therapeutic use
D001639:Bicarbonates; D002021:Buffers; D002254:Carbonates; D004338:Drug Combinations; C046283:sodium bicarbonate, sodium carbonate drug combination; D014325:Tromethamine; D002245:Carbon Dioxide; D017693:Sodium Bicarbonate; D003999:Dichloroacetic Acid; D012964:Sodium; D010100:Oxygen